On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- Defining cationic peptides
- Cationic peptides in innate immunity
- The Cathelicidins
- The Defensins
- Antibiotic activity in vitro (1)
- Cationic peptides have a broad spectrum activity
- Antibiotic activity in vitro (2)
- Mechanism of action of cationic peptides
- Multiple mechanisms of killing microbes
- Physiological conditions and antibiotic activity(1)
- Physiological conditions and antibiotic activity(2)
- Bacterial evasion mechanism
- Bacterial evasion - the example of Shigella flexneri
- In vivo data regarding antibiotic activity
- Antimicrobial activity depends upon leukocytes
- Cationic peptides as immunomodulators
- Antimicrobial or host defence peptides?
- Are there receptors for defensins?
- CCR6 and defensin mediated chemotaxis
- Do the defensins function via the TLRs?
- Are there receptors for other CAMPs?
- Do the cathelicidins have dedicated receptors?
- Role in human disease - Mtb infection (1)
- Role in human disease - Mtb infection (2)
- Role in skin diseases (1)
- Role in skin diseases (2)
- Pro or anti inflammatory? LPS & IL-6
- Pro or anti inflammatory? IL-8
- LL37 and leukocyte accumulation theories (1)
- LL37 and leukocyte accumulation theories (2)
- LPS vs. IL-1beta stimulation
- Prevalence of Superbugs
- Cationic peptides as potential drug targets (1)
- Cationic peptides as potential drug targets (2)
- Cationic peptides as potential drug targets (3)
- Spot synthesis of peptides using a pipetting robot
- Isolation of active 8-amino acid peptides
- Future directions
Topics Covered
- Cationic peptides: a definition
- The cathelicidins
- The defensins
- Antibiotic activity in vitro
- Antibiotic activity: mechanisms of action
- Antibiotic activity under physiologic conditions and in vivo
- Bacterial evasion
- Cationic peptides as immunomodulators
- Are interactions with host cells receptor mediated or are there other mechanisms of action?
- Role in human infectious disease, e.g. Mycobacterium tuberculosis infection
- Role in human inflammatory disease, e.g. psoriasis
- gla-3- Are cationic peptides pro- or anti-inflammatory?
- Cationic peptides as drug targets
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Bowdish, D. (2009, June 30). Cationic peptides in innate immunity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/HSHM8408.Export Citation (RIS)
Publication History
- Published on June 30, 2009
Financial Disclosures
- Dr. Dawn Bowdish has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.